Microbiota and metabolic diseases
- PMID: 29721802
- DOI: 10.1007/s12020-018-1605-5
Microbiota and metabolic diseases
Abstract
The microbiota is a complex ecosystem of microorganisms consisting of bacteria, viruses, protozoa, and fungi, living in different districts of the human body, such as the gastro-enteric tube, skin, mouth, respiratory system, and the vagina. Over 70% of the microbiota lives in the gastrointestinal tract in a mutually beneficial relationship with its host. The microbiota plays a major role in many metabolic functions, including modulation of glucose and lipid homeostasis, regulation of satiety, production of energy and vitamins. It exerts a role in the regulation of several biochemical and physiological mechanisms through the production of metabolites and substances. In addition, the microbiota has important anti-carcinogenetic and anti-inflammatory actions. There is growing evidence that any modification in the microbiota composition can lead to several diseases, including metabolic diseases, such as obesity and diabetes, and cardiovascular diseases. This is because alterations in the microbiota composition can cause insulin resistance, inflammation, vascular, and metabolic disorders. The causes of the microbiota alterations and the mechanisms by which microbiota modifications can act on the development of metabolic and cardiovascular diseases have been reported. Current and future preventive and therapeutic strategies to prevent these diseases by an adequate modulation of the microbiota have been also discussed.
Keywords: Cardiovascular disease; Diabetes; Metabolic syndrome; Microbiome; Microbiota; Obesity.
Similar articles
-
Emerging role of intestinal microbiota and microbial metabolites in metabolic control.Diabetologia. 2017 Apr;60(4):613-617. doi: 10.1007/s00125-016-4192-0. Epub 2016 Dec 24. Diabetologia. 2017. PMID: 28013341
-
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.Cell Rep. 2016 Jul 19;16(3):731-43. doi: 10.1016/j.celrep.2016.06.027. Epub 2016 Jun 30. Cell Rep. 2016. PMID: 27373162
-
[Gut microbiota and immune crosstalk in metabolic disease].Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682223 Review. French.
-
Gut microbiota in health and disease: an overview focused on metabolic inflammation.Benef Microbes. 2016;7(2):181-94. doi: 10.3920/bm2015.0062. Epub 2015 Dec 8. Benef Microbes. 2016. PMID: 26645350 Review.
-
Role of the gut microbiota in type 2 diabetes and related diseases.Metabolism. 2021 Apr;117:154712. doi: 10.1016/j.metabol.2021.154712. Epub 2021 Jan 23. Metabolism. 2021. PMID: 33497712 Review.
Cited by
-
High fat diet increases the severity of collagen-induced arthritis in mice by altering the gut microbial community.Adv Rheumatol. 2024 May 30;64(1):44. doi: 10.1186/s42358-024-00382-y. Adv Rheumatol. 2024. PMID: 38816873
-
Postbiotics as Metabolites and Their Biotherapeutic Potential.Int J Mol Sci. 2024 May 16;25(10):5441. doi: 10.3390/ijms25105441. Int J Mol Sci. 2024. PMID: 38791478 Free PMC article. Review.
-
An altered gut microbiome in pre-eclampsia: cause or consequence.Front Cell Infect Microbiol. 2024 May 7;14:1352267. doi: 10.3389/fcimb.2024.1352267. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38774629 Free PMC article. Review.
-
Food for thought: Making the case for food produced via regenerative agriculture in the battle against non-communicable chronic diseases (NCDs).One Health. 2024 Apr 20;18:100734. doi: 10.1016/j.onehlt.2024.100734. eCollection 2024 Jun. One Health. 2024. PMID: 38711478 Free PMC article. Review.
-
Colon impairments and inflammation driven by an altered gut microbiota leads to social behavior deficits rescued by hyaluronic acid and celecoxib.BMC Med. 2024 Apr 29;22(1):182. doi: 10.1186/s12916-024-03323-0. BMC Med. 2024. PMID: 38685001 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical